DOI 10.1016/j.avsg.2025.05.039
Two-Year Outcomes of Drug-Coated Balloons versus Standard Balloons for Femoropopliteal Artery In-Stent Restenosis: Evidence from the AcoArt I Trial.
Аннотация
BACKGROUND
To assess the midterm efficacy and safety of drug-coated balloons (DCBs) compared with standard percutaneous transluminal angioplasty (PTA) in the treatment of femoropopliteal artery in-stent restenosis in the AcoArt I trial.
METHODS
The AcoArt I trial was a prospective, multicentered, randomized clinical study of 50 patients with femoropopliteal artery in-stent restenosis treated with either paclitaxel-coated balloon angioplasty (DCB group; n = 27) or standard PTA (PTA group; n = 23). Primary patency and clinical outcomes were assessed at 6, 12, and 24 months postoperatively.
RESULTS
Over a 24-month period, the primary patency rate of the DCB group was significantly higher than that of the PTA group (P < 0.001), with Kaplan-Meier curves demonstrating sustained superiority at all time points (6 month: 100% vs. 55%; 12 month: 87.5% vs. 15%; and 24 month: 54.2% vs. 5%). The hazard ratio for primary patency between DCB and PTA was 8.35 (95% confidence interval: 3.72-18.74,P < 0.001). In addition, the DCB group demonstrated a significantly higher rate of freedom from clinically driven target lesion revascularization than the PTA group (88.0% vs. 31.8%; P < 0.001). The incidence of major adverse events did not significantly differ between groups.
CONCLUSION
The use of paclitaxel-coated balloon catheters improved the angiographic and midterm clinical outcomes in most patients with in-stent restenosis.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.